Letters to the Editor
Efficacy of rituximab treatment in a post-COVID-19 vaccine myositis overlapping to systemic sclerosis: a histological follow-up
F. Bandinelli1, G. Dallagiacoma2, F. Nozzoli3, M. Capassoni4, R. Nassini5
- SOC of Rheumatology, Multi-Dimensional Department, Santa Maria Nuova and San Giovanni di Dio Hospitals, USL Tuscany Center, Florence, Italy. francesca.bandi@gmail.com
- SOC of Rheumatology, Multi-Dimensional Department, Santa Maria Nuova and San Giovanni di Dio Hospitals, USL Tuscany Center, Florence, Italy.
- Department of Health Sciences, Section of Pathological Anatomy, University of Florence, Italy.
- SOC of Rheumatology, Multi-Dimensional Department, USL Tuscany Center, Prato, Italy.
- Department of Health Sciences and Headache Center, Clinical Pharmacology Unit, Section of Clinical Pharmacology and Oncology, Careggi University Hospital, University of Florence, Italy.
CER19104
2026 Vol.44, N°2
PI 0415, PF 0416
Letters to the Editor
Free to view
(click on article PDF icon to read the article)
PMID: 41678174 [PubMed]
Received: 15/07/2025
Accepted : 12/09/2025
In Press: 30/01/2026
Published: 24/02/2026


